Lyndsay Willmott, MD, discusses the case of a 57-year-old woman with ovarian cancer and the available treatment options.
EP. 1: Case Presentation: A 57-Year-Old Woman With Ovarian Cancer
Lyndsay Willmott, MD, presents the case of a 57-year-old woman with ovarian cancer.
EP. 2: Molecular Testing: Ovarian Cancer
An oncologist explains the importance of molecular testing in ovarian cancer and the implications of testing on treatment selection.
EP. 3: First-Line Therapies in Ovarian Cancer
Dr. Lyndsay Willmott discusses the front-line therapy options for ovarian cancer and the factors considered in choosing maintenance therapies.
EP. 4: Rucaparib Maintenance Therapy in Ovarian Cancer: The ARIEL3 Trial
A key opinion leader shares data from a phase III, ARIEL3, clinical trial on rucaparib maintenance treatment for ovarian cancer.
EP. 5: Toxicities With PARP Inhibitors for Ovarian Cancer
Lyndsay Willmott, MD, explains the tolerability of PARP inhibitors for ovarian cancer and how to discuss dose reductions with patients.
EP. 6: Future Treatments in Ovarian Cancer
An expert reviews the ongoing ARIEL4 phase III trial and explains what the future of ovarian cancer treatment looks like.
2 Clarke Drive Cranbury, NJ 08512